HLK Biotech Holding Group, Inc. (AMHD)

0.0003 0.0000 (0.00%) At close: 09:30AM EDT

HLK Biotech Holding Group, Inc.

2612 Granby Street
Norfolk, VA 23517
United States
646-926-3568
https://www.amelotholdings.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Anna Petinova	Interim VP of Admin., Interim VP of Fin., Treasurer and Director	N/A	N/A	1964
Mr. Hank Midden	VP - Operations	N/A	N/A	1942
Mr. John Gernannt	Head of Investor & PR Issues	N/A	N/A	N/A
Mr. Peter R. N. Maharaj	VP - Marketing and Pres - Southern Hardwoods	N/A	N/A	1966
Mr. Thomas Cripe	Sr. VP of Bus. & Technology Devel.	N/A	N/A	N/A
Mr. Tyler Macallister	Controller	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia.

Corporate governance

HLK Biotech Holding Group, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.